Clinical Trials Directory

Trials / Unknown

UnknownNCT03760315

mNGS vs Culture Critically Ill Patients

Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China;

Status
Unknown
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

mNGS is popular in research and recently it has been used clinically to detect microbes in the blood or other secretion in infected patients for quicker ,broad and accurate detection of microbes. In ICU ,patients are critically ill and need quicker and accurate antibiotics use to stop the pathologic process. The purpose of this study was to determine whether the positive detection rate of pathogens in patients with sepsis by metagenomic full-targeted detection technology was higher than that in blood culture, and to determine whether the pathogens found in patients with sepsis by metagenomic full-targeted detection technology were important for clinical development. Anti-infective regimens can help.

Detailed description

Sepsis patients in ICU were took blood culture sample and blood sample for mNGS test (IDSeqTM Ultra, Combing with Metagenomics and Pathogen/AMR/VF Probe Enrichment). Clinicians use their knowledge and experience to decide antibiotics use with the guide of Culture results or mNGS results. Validation with digital droplet PCR assays when metagenomic full-targeted assays identify pathogens not identified in conventional blood cultures The difference between the positive rate of mNGS and the positive rate of blood culture were recorded. Patient were followed at least 28 days after enrollment or an outcome indicator. Possible scenarios for detecting clinical impact were detected. Etiology, biochemical indicators, immune function, infection indicator, secondary infection, SOFA score and length of stay,outcome were recorded.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTblood mNGS (IDSeqTM Ultra); blood Culturetake blood samples for mNGS and Culture at the same time in sepsis patients. No intervention on the treatment of the patients.

Timeline

Start date
2022-04-01
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2018-11-30
Last updated
2022-08-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03760315. Inclusion in this directory is not an endorsement.